Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
Because adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the quality and timeliness of cancer care in this population has emerged as a priority area. To identify current trends in AYA care, we examined patter...
Uložené v:
| Vydané v: | Journal of clinical oncology Ročník 29; číslo 30; s. 4045 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
20.10.2011
|
| Predmet: | |
| ISSN: | 1527-7755, 1527-7755 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Because adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the quality and timeliness of cancer care in this population has emerged as a priority area. To identify current trends in AYA care, we examined patterns of clinical trial participation, time to treatment, and provider characteristics in a population-based sample of AYA patients with cancer.
Using the National Cancer Institute Patterns of Care Study, we used multivariate logistic regression to evaluate demographic and provider characteristics associated with clinical trial enrollment and time to treatment among 1,358 AYA patients with cancer (age 15 to 39 years) identified through the Surveillance, Epidemiology, and End Results Program.
In our study, 14% of patients age 15 to 39 years had enrolled onto a clinical trial; participation varied by type of cancer, with the highest participation in those diagnosed with acute lymphoblastic leukemia (37%) and sarcoma (32%). Multivariate analyses demonstrated that uninsured, older patients and those treated by nonpediatric oncologists were less likely to enroll onto clinical trials. Median time from pathologic confirmation to first treatment was 3 days, but this varied by race/ethnicity and cancer site. In multivariate analyses, advanced cancer stage and outpatient treatment alone were associated with longer time from pathologic confirmation to treatment.
Our study identified factors associated with low clinical trial participation in AYA patients with cancer. These findings support the continued need to improve access to clinical trials and innovative treatments for this population, which may ultimately translate into improved survival. |
|---|---|
| AbstractList | Because adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the quality and timeliness of cancer care in this population has emerged as a priority area. To identify current trends in AYA care, we examined patterns of clinical trial participation, time to treatment, and provider characteristics in a population-based sample of AYA patients with cancer.
Using the National Cancer Institute Patterns of Care Study, we used multivariate logistic regression to evaluate demographic and provider characteristics associated with clinical trial enrollment and time to treatment among 1,358 AYA patients with cancer (age 15 to 39 years) identified through the Surveillance, Epidemiology, and End Results Program.
In our study, 14% of patients age 15 to 39 years had enrolled onto a clinical trial; participation varied by type of cancer, with the highest participation in those diagnosed with acute lymphoblastic leukemia (37%) and sarcoma (32%). Multivariate analyses demonstrated that uninsured, older patients and those treated by nonpediatric oncologists were less likely to enroll onto clinical trials. Median time from pathologic confirmation to first treatment was 3 days, but this varied by race/ethnicity and cancer site. In multivariate analyses, advanced cancer stage and outpatient treatment alone were associated with longer time from pathologic confirmation to treatment.
Our study identified factors associated with low clinical trial participation in AYA patients with cancer. These findings support the continued need to improve access to clinical trials and innovative treatments for this population, which may ultimately translate into improved survival. Because adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the quality and timeliness of cancer care in this population has emerged as a priority area. To identify current trends in AYA care, we examined patterns of clinical trial participation, time to treatment, and provider characteristics in a population-based sample of AYA patients with cancer.PURPOSEBecause adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the quality and timeliness of cancer care in this population has emerged as a priority area. To identify current trends in AYA care, we examined patterns of clinical trial participation, time to treatment, and provider characteristics in a population-based sample of AYA patients with cancer.Using the National Cancer Institute Patterns of Care Study, we used multivariate logistic regression to evaluate demographic and provider characteristics associated with clinical trial enrollment and time to treatment among 1,358 AYA patients with cancer (age 15 to 39 years) identified through the Surveillance, Epidemiology, and End Results Program.METHODSUsing the National Cancer Institute Patterns of Care Study, we used multivariate logistic regression to evaluate demographic and provider characteristics associated with clinical trial enrollment and time to treatment among 1,358 AYA patients with cancer (age 15 to 39 years) identified through the Surveillance, Epidemiology, and End Results Program.In our study, 14% of patients age 15 to 39 years had enrolled onto a clinical trial; participation varied by type of cancer, with the highest participation in those diagnosed with acute lymphoblastic leukemia (37%) and sarcoma (32%). Multivariate analyses demonstrated that uninsured, older patients and those treated by nonpediatric oncologists were less likely to enroll onto clinical trials. Median time from pathologic confirmation to first treatment was 3 days, but this varied by race/ethnicity and cancer site. In multivariate analyses, advanced cancer stage and outpatient treatment alone were associated with longer time from pathologic confirmation to treatment.RESULTSIn our study, 14% of patients age 15 to 39 years had enrolled onto a clinical trial; participation varied by type of cancer, with the highest participation in those diagnosed with acute lymphoblastic leukemia (37%) and sarcoma (32%). Multivariate analyses demonstrated that uninsured, older patients and those treated by nonpediatric oncologists were less likely to enroll onto clinical trials. Median time from pathologic confirmation to first treatment was 3 days, but this varied by race/ethnicity and cancer site. In multivariate analyses, advanced cancer stage and outpatient treatment alone were associated with longer time from pathologic confirmation to treatment.Our study identified factors associated with low clinical trial participation in AYA patients with cancer. These findings support the continued need to improve access to clinical trials and innovative treatments for this population, which may ultimately translate into improved survival.CONCLUSIONOur study identified factors associated with low clinical trial participation in AYA patients with cancer. These findings support the continued need to improve access to clinical trials and innovative treatments for this population, which may ultimately translate into improved survival. |
| Author | Harlan, Linda C Stevens, Jennifer L Parsons, Helen M Seibel, Nita L Keegan, Theresa H M |
| Author_xml | – sequence: 1 givenname: Helen M surname: Parsons fullname: Parsons, Helen M email: helen.parsons@nih.gov organization: Applied Research Program, National Cancer Institute, Bethesda, MD 20892-7344, USA. helen.parsons@nih.gov – sequence: 2 givenname: Linda C surname: Harlan fullname: Harlan, Linda C – sequence: 3 givenname: Nita L surname: Seibel fullname: Seibel, Nita L – sequence: 4 givenname: Jennifer L surname: Stevens fullname: Stevens, Jennifer L – sequence: 5 givenname: Theresa H M surname: Keegan fullname: Keegan, Theresa H M |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21931022$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LAzEQhoNUbP24e5LcPLUm2U0360Wk-IngRc9lNpmt0d2kJlnEf-LPNdUKXmaG530YmNknI-cdEnLM2YwLxs7uF48zwTifFfOZqGW5QyZcimpaVVKO_s1jsh_jK2O8VIXcI2PB64IzISbka9FZZzV0NAWb6xpCstquIVnvKDhDk-2RJp9zhNSjSxR671YUjO8w6gzij_fphx86dBl82PRCNTiN4Zwaj1lZIYVEjYWV89FG6gO1Lg5hI9Ee3nKc07bFgJlcHJLdFrqIR9t-QJ6vr54Wt9OHx5u7xeXDVJeySlOpinZeK1A4Nw1CWUKjdFm0TJmiamsjJeNaKGYaoTQXxsAmEAWapmmVkuKAnP7uXQf_PmBMy97mq7oOHPohLmvG5kIqvjFPtubQ9GiW62B7CJ_Lv2eKb6X9e4o |
| CitedBy_id | crossref_primary_10_1001_jamanetworkopen_2023_28153 crossref_primary_10_1111_ecc_12476 crossref_primary_10_1634_theoncologist_2014_0265 crossref_primary_10_1016_j_bulcan_2020_09_004 crossref_primary_10_1111_bjh_12556 crossref_primary_10_3322_caac_21585 crossref_primary_10_1542_peds_2014_0122C crossref_primary_10_1097_MPH_0000000000003066 crossref_primary_10_1542_peds_2014_0122B crossref_primary_10_1542_peds_2014_0122E crossref_primary_10_4103_ijmpo_ijmpo_185_20 crossref_primary_10_1053_j_seminoncol_2018_04_002 crossref_primary_10_1542_peds_2014_0122G crossref_primary_10_1542_peds_2014_0122I crossref_primary_10_1080_00981389_2019_1640338 crossref_primary_10_1002_pbc_27033 crossref_primary_10_3171_2015_2_JNS142960 crossref_primary_10_1089_jayao_2015_0041 crossref_primary_10_1097_MS9_0000000000001398 crossref_primary_10_3322_caac_21731 crossref_primary_10_1002_cncr_29193 crossref_primary_10_1089_jayao_2020_0041 crossref_primary_10_1371_journal_pone_0230824 crossref_primary_10_1177_107327481602300414 crossref_primary_10_1002_cncr_29870 crossref_primary_10_1002_pon_3730 crossref_primary_10_1002_cam4_4292 crossref_primary_10_1002_cncr_33855 crossref_primary_10_1002_cncr_34702 crossref_primary_10_1186_s12909_024_06164_w crossref_primary_10_1007_s11912_022_01276_2 crossref_primary_10_1089_jayao_2019_0107 crossref_primary_10_1089_jayao_2021_0187 crossref_primary_10_1200_JCO_2012_47_3173 crossref_primary_10_1002_pbc_27426 crossref_primary_10_3322_caac_21565 crossref_primary_10_3390_ijms23073540 crossref_primary_10_1001_jama_2019_15040 crossref_primary_10_1007_s40124_015_0075_y crossref_primary_10_1111_bjh_15640 crossref_primary_10_1001_jamanetworkopen_2021_16248 crossref_primary_10_1002_cncr_29982 crossref_primary_10_1002_cncr_27685 crossref_primary_10_1093_oncolo_oyaf180 crossref_primary_10_1089_jayao_2024_0095 crossref_primary_10_1097_MOP_0000000000001200 crossref_primary_10_2196_17078 crossref_primary_10_1002_cncr_29869 crossref_primary_10_1200_JCO_2011_39_6333 crossref_primary_10_1159_000363434 crossref_primary_10_1038_nrclinonc_2015_92 crossref_primary_10_1089_jayao_2021_0110 crossref_primary_10_3390_children6110117 crossref_primary_10_1089_jayao_2013_0030 crossref_primary_10_1007_s11764_013_0332_4 crossref_primary_10_1007_s11764_021_01161_0 crossref_primary_10_1089_jayao_2021_0008 crossref_primary_10_1080_10428194_2025_2499607 crossref_primary_10_1007_s00520_016_3558_7 crossref_primary_10_1016_j_canep_2016_09_013 crossref_primary_10_1016_j_clml_2014_12_006 crossref_primary_10_1177_10732748251364041 crossref_primary_10_4251_wjgo_v12_i12_1394 crossref_primary_10_1136_bmjopen_2017_017052 crossref_primary_10_1371_journal_pone_0154985 crossref_primary_10_1002_pbc_27486 crossref_primary_10_2196_37054 crossref_primary_10_1016_S1470_2045_17_30100_6 crossref_primary_10_1002_pbc_24231 crossref_primary_10_1053_j_seminoncol_2015_07_012 crossref_primary_10_2217_cpr_12_30 crossref_primary_10_1002_pbc_27074 crossref_primary_10_1002_cncr_31127 crossref_primary_10_1089_jayao_2021_0014 crossref_primary_10_1245_s10434_012_2621_y crossref_primary_10_1002_pbc_27235 crossref_primary_10_1007_s10880_021_09764_6 crossref_primary_10_1089_jayao_2019_0139 crossref_primary_10_1002_cam4_1307 crossref_primary_10_1007_s10147_021_02064_x crossref_primary_10_1016_j_clml_2020_06_010 crossref_primary_10_1200_OP_24_01075 crossref_primary_10_1097_COC_0000000000000327 crossref_primary_10_1002_pbc_30592 crossref_primary_10_1016_j_soncn_2015_05_006 crossref_primary_10_3390_cancers14102451 crossref_primary_10_1016_j_soncn_2015_05_001 crossref_primary_10_1089_jayao_2021_0026 crossref_primary_10_1093_nop_npab001 crossref_primary_10_1007_s40471_022_00286_9 crossref_primary_10_1186_s12884_021_03854_x crossref_primary_10_1002_pbc_28315 crossref_primary_10_1002_pbc_25843 crossref_primary_10_1007_s12529_023_10162_5 crossref_primary_10_1080_10428194_2019_1574002 crossref_primary_10_1002_pbc_26638 crossref_primary_10_1007_s11764_012_0219_9 crossref_primary_10_1038_s41598_022_07703_5 crossref_primary_10_1016_j_ejim_2016_06_026 crossref_primary_10_1200_EDBK_323523 crossref_primary_10_1002_ijc_28231 crossref_primary_10_1089_jayao_2014_0041 crossref_primary_10_1097_MD_0000000000027560 crossref_primary_10_1200_JCO_2016_70_3249 crossref_primary_10_1002_cncr_32038 crossref_primary_10_1089_jayao_2019_0078 crossref_primary_10_1002_cncr_29669 crossref_primary_10_1182_bloodadvances_2017014944 crossref_primary_10_2196_48761 crossref_primary_10_1002_pbc_29479 crossref_primary_10_1093_oncolo_oyac030 crossref_primary_10_1371_journal_pone_0280638 crossref_primary_10_1002_cncr_32675 crossref_primary_10_1089_jayao_2022_0006 crossref_primary_10_3390_cancers13112675 crossref_primary_10_1001_jamanetworkopen_2021_21888 crossref_primary_10_1089_jayao_2018_0140 crossref_primary_10_3322_caac_21235 crossref_primary_10_1002_cncr_33190 crossref_primary_10_1002_cncr_31727 crossref_primary_10_1002_cam4_2891 crossref_primary_10_1002_cncr_28685 crossref_primary_10_1089_jayao_2012_0024 crossref_primary_10_1007_s00520_013_1809_4 crossref_primary_10_1097_j_pain_0000000000002893 crossref_primary_10_1089_jayao_2017_0060 crossref_primary_10_1089_jayao_2012_0029 crossref_primary_10_3322_caac_21349 crossref_primary_10_3109_10428194_2015_1083562 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1200/JCO.2011.36.2954 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1527-7755 |
| ExternalDocumentID | 21931022 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: N01 PC035139 – fundername: NCI NIH HHS grantid: N01-PC-35135 – fundername: NCI NIH HHS grantid: N01 PC054402 – fundername: NCI NIH HHS grantid: N01-PC-54403 – fundername: NCI NIH HHS grantid: N01 PC035138 – fundername: NCI NIH HHS grantid: N01 PC035145 – fundername: NCI NIH HHS grantid: N01 PC054405 – fundername: NCI NIH HHS grantid: N01 PC035141 – fundername: NCI NIH HHS grantid: N01-PC-35143 – fundername: NCI NIH HHS grantid: N01 PC035135 |
| GroupedDBID | --- .55 0R~ 18M 2WC 34G 39C 3O- 4.4 53G 5GY 5RE 8F7 AARDX AAWTL AAYEP ABBLC ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV AEGXH AENEX AFFNX AI. AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL C45 CGR CS3 CUY CVF DIK EBS ECM EIF EJD F5P F9R FBNNL FD8 GX1 H13 HZ~ IH2 KQ8 L7B LSO MJL N9A NPM O9- OK1 OVD OWW P2P QTD R1G RHI RLZ RUC SJN TEORI TR2 TWZ UDS VH1 VVN WH7 X7M YFH YQY 7X8 |
| ID | FETCH-LOGICAL-c457t-583f698a8e6dbea44ab8c43f08d37f9d5501c280db28c12dda8d3723edbbf8852 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 159 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000296551700021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1527-7755 |
| IngestDate | Fri Sep 05 13:37:58 EDT 2025 Mon Jul 21 06:03:06 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 30 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c457t-583f698a8e6dbea44ab8c43f08d37f9d5501c280db28c12dda8d3723edbbf8852 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.36.2954?role=tab |
| PMID | 21931022 |
| PQID | 900625815 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_900625815 pubmed_primary_21931022 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-10-20 |
| PublicationDateYYYYMMDD | 2011-10-20 |
| PublicationDate_xml | – month: 10 year: 2011 text: 2011-10-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of clinical oncology |
| PublicationTitleAlternate | J Clin Oncol |
| PublicationYear | 2011 |
| SSID | ssj0014835 |
| Score | 2.4475062 |
| Snippet | Because adolescent and young adult (AYA) patients with cancer have experienced variable improvement in survival over the past two decades, enhancing the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 4045 |
| SubjectTerms | Adolescent Adult Age Factors Clinical Trials as Topic - statistics & numerical data Female Humans Logistic Models Male Neoplasms - epidemiology Neoplasms - therapy Patient Selection Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Research Subjects Sarcoma - epidemiology Sarcoma - therapy SEER Program United States - epidemiology Young Adult |
| Title | Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21931022 https://www.proquest.com/docview/900625815 |
| Volume | 29 |
| WOSCitedRecordID | wos000296551700021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELXYhLiw74vmgDgRSO0sDheEEBVCaukBpN4qb0EVkJSmIPVP-Fw8jku5IA5ccrETRfJkMuP3_B4hxwi1qVCyIGRxYhsUEQaoQhaYTMqEaikFzZ3ZRNpu824363huTuVplZOc6BK1LhXukZ9neNov5o34cvAWoGkUgqveQWOWzDNbySCjK-1OQYSIO39NNG61RWQce5TSxsX53fV9Ld_JkjNEun6vL91_prnyzzdcJcu-wISrOiLWyIwp1sliy0Po6-SkU4tVj0_hYXr2qjqFE-hMZazHG-TTS4a-gHP2gIH4wcAGUWhAX3oYlfBNVgdnXQQ_VKLcvDFmFHBKHxXgxi8ojLXhBejS2ClPBsQIdE3661dQDgEp8mj5YeBVPNthmBi5KHO5SR6bNw_Xt4H3cQhUFKcjPNiVJxkX3CRaGhFFQnIVsTzkmqV5pm2T1FCUh1pSrhpUa4EDlBkbKjnnMd0ic0VZmB0CUlGlmG25ZKoiJSMZ2yenmmlbCUqa8l0Ck7Xp2e8EwQ9RmPK96n2vzi7Zrte3N6j1PHo2aTNsfPf-vnmfLFFPAqThAZnPbY4wh2RBfYz61fDIxZ-9tjutL1gI6A0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+trial+participation+and+time+to+treatment+among+adolescents+and+young+adults+with+cancer%3A+does+age+at+diagnosis+or+insurance+make+a+difference%3F&rft.jtitle=Journal+of+clinical+oncology&rft.au=Parsons%2C+Helen+M&rft.au=Harlan%2C+Linda+C&rft.au=Seibel%2C+Nita+L&rft.au=Stevens%2C+Jennifer+L&rft.date=2011-10-20&rft.issn=1527-7755&rft.eissn=1527-7755&rft.volume=29&rft.issue=30&rft.spage=4045&rft_id=info:doi/10.1200%2FJCO.2011.36.2954&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-7755&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-7755&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-7755&client=summon |